☆
Watchlist
Log in
Sign-up
Medigard Ltd (mgz) Logo

Medigard Ltd (MGZ)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials (10-yr)

MGZ Chart

Snapshot

MGZ's Principal Activity is the medical technologies innovation and research and development; acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product; progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium Medical Products Co., Ltd on the Blood Collection Device and the Flash Back Needle. The licence was terminated after the end of the financial year.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) +8.68%
vs ASX 200 (1yr) +8.24%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,332 of 2,422
Sector Rank 205 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies MEB / EZZ / ANR
EPS $0.00
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

MGZ is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Date Heading Pages File Size Time

Corporate Overview

Medigard Limited (MGZ) is involved in medical technologies innovation and research and development, acquisition of a licence to utilise intellectual property to advance the KT009 project to treat degenerative disk disease with an injectable product, progressing and maintenance of patents and conduct of our licence arrangement and liaison with Shanghai Sol-Millennium MedicalProducts Co., Ltd on the Blood Collection Device and the Flash Back Needle.

Incorporation Details

Incorporated Medigard Limited was incorporated on 18 October 1999 in Queensland.

Corporate Details

Head Office
Website -
Registry BoardRoom
Auditor N/A
Date Listed 5 Feb 2004

Upcoming Calendar (Forecasted)

No calendar entries available.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Dr Ian Edward Dixon Executive Director Nov 2017

Dr Ian Edward Dixon

Executive Director

Dr Dixon is a Managing Director and owner of Altnia Group, a biotechnology company with a portfolio of human therapeutic products and technologies. Dr Dixon is a co-inventor of a number of technologies and was the head of the Invetech Product Group, a leading medical device development business. Dr Dixon has direct experience in product innovation, technology commercialisation, partnering and capital raising.
Mr Craig Duncan Cameron Non-Executive Director Nov 2016

Mr Craig Duncan Cameron

Non-Executive Director

Mr Cameron has almost 30 years' CEO and board experience in a broad range of industries working in the USA, Canada, Japan, Australia, New Zealand and the UK running start-ups, turnarounds and mature businesses in IT services, nutraceuticals, information technology, communications, healthcare, green tech and clean technology industries.
Dr Christopher Jan Bishop Non-Executive Director,Non-Executive Chairman Sep 2008

Dr Christopher Jan Bishop

Non-Executive Director,Non-Executive Chairman

Dr Bishop has experience in the development and manufacture of sophisticated electronic products including medical instruments.
Ms Patricia Mary Boero Chief Financial Officer,Alternate Director - Donald Channer,Company Secretary Mar 2006

Ms Patricia Mary Boero

Chief Financial Officer,Alternate Director - Donald Channer,Company Secretary

Ms Boero has experience in accounting and financial services across a broad range of industries.
Mr Donald Julian Channer Non-Executive Director Oct 1999

Mr Donald Julian Channer

Non-Executive Director

Mr Channer served as Chairman of the Company from incorporation until 20 October 2017. He has been involved in many private companies as both director and chairman.

Director Transactions

MGZ directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
09/12/19 Christopher Bishop Issued 1,818,570 $0.014 $25,460 Issue of securities
09/12/19 Craig Cameron Issued 1,454,856 $0.014 $20,368 Issue of securities
09/12/19 Donald Channer Issued 7,142,857 $0.014 $100,000 Issue of securities
09/12/19 Ian Dixon Issued 14,608,569 $0.014 $204,520 Issue of securities
09/12/19 Donald Channer Issued 7,142,857 $0.014 $100,000 Issue of securities

Director Interests

The current holdings of MGZ directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Christopher Bishop 09/12/2019 283,334 7,032,855 94,445 N/A
Craig Cameron 09/12/2019 0 2,454,856 N/A N/A
Donald Channer 09/12/2019 37,689,120 11,708,861 9,039,231 N/A
Ian Dixon 09/12/2019 0 16,037,140 80,000,000 N/A
Patricia Boero 29/08/2019 725,829 4,978,571 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Jun 30, 2020.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
No shareholder information disclosed 0 0.00%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

No Substantial Shareholders for MGZ in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2020 $0.02 30 June
2019 $0.02 28 June
2018 $0.016 29 June
2017 $0.011 28 June
2016 $0.038 28 June
2015 $0.075 30 June
2014 $0.023 30 June
MGZ Historical Price Data (CSV)
Up to 20 years of EOD share price history
Sign up to Download
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.